A detailed history of Pdt Partners, LLC transactions in Bioventus Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 55,229 shares of BVS stock, worth $370,586. This represents 0.02% of its overall portfolio holdings.

Number of Shares
55,229
Previous 13,157 319.77%
Holding current value
$370,586
Previous $120,000 204.17%
% of portfolio
0.02%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$6.2 - $9.51 $260,846 - $400,104
42,072 Added 319.77%
55,229 $365,000
Q1 2025

May 15, 2025

BUY
$8.76 - $11.05 $115,255 - $145,384
13,157 New
13,157 $120,000

Others Institutions Holding BVS

About Bioventus Inc.


  • Ticker BVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 61,664,200
  • Market Cap $414M
  • Description
  • Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...
More about BVS
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.